- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Rodin Therapeutics Inc.
Headquarters: Cambridge, MA, United States
Website: N/A
Year Founded: 2013
Status: Acquired
BioCentury | Sep 30, 2022
Management Tracks
Sullivan becomes CBO at Prilenia
Plus new CMO at Cellectis, and updates from Lyell, Adrestia, Mursla and more
BioCentury | Aug 7, 2019
Company News
Management tracks: Gilead's McHutchison joins Assembly as CEO; plus Lilly, Vor, HiberCell, insitro and more
BioCentury | May 4, 2019
Product Development
Amyloid: how did we get here and what can we learn?
Lessons for industry from nearly 20 years of amyloid failures
BioCentury | Jan 11, 2019
Product R&D
Biomarkers’ road less traveled
Why FDA’s biomarker guidance means consortia will still be in the driver’s seat
BioCentury | Apr 14, 2016
Emerging Company Profile
Thinking about HDAC2
Rodin's safe, selective HDAC2 inhibitors for AD
Items per page:
1 - 10 of 27